<DOC>
	<DOC>NCT02303522</DOC>
	<brief_summary>An historical data comparator study for children with relapsed/refactory acute lymphoblastic leukemia (ALL).</brief_summary>
	<brief_title>Historical Data Analysis of Complete Remission in Children With R/R Acute Lymphoblastic Leukemia (ALL)</brief_title>
	<detailed_description>A retrospective observational study reviewing historical complete remission for pediatric patients who had either relapsed or refractory B-precursor acute lymphoblastic leukemia (ALL)</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<mesh_term>Leukemia, Lymphoid</mesh_term>
	<criteria>Inclusion criteria: Pediatric (age less than 18 years) patients with relapsed or refractory Bcell precursor ALL, specifically those with 2nd or later relapse after chemotherapy (with no prior transplantation), Relapse after HSCT, or Refractory disease Had treatment for relapsed or refractory disease between 20052012 Has data available on ALL treatment, including number of salvage treatments, response status after therapies, and HSCT Exclusion criteria: No CNS involvement at relapse No previous treatment with blinatumomab</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>ALL, pediatric, leukemia, childhood, lymphoblastic, lymphoma, acute, Precursor Cell</keyword>
</DOC>